Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma
Journal of the Formosan Medical Association
Luo, Pei-Jui (Autor:in) / Chuang, Kai-I (Autor:in) / Ni, Cheng-Fu (Autor:in) / Yeh, Hsiao-Yu (Autor:in) / Wu, Ming-Shun (Autor:in) / Hsieh, Yao-Yu (Autor:in) / Kao, Wei-Yu (Autor:in) / Wu, Chih-Horng (Autor:in)
01.01.2025
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Lactylation‐Driven HECTD2 Limits the Response of Hepatocellular Carcinoma to Lenvatinib
Wiley | 2025
|Hepatocellular carcinoma disguised as liver abscesses
British Library Online Contents | 2018
|BASE | 2013
|Social network associated with depressed mood and sarcopenia among older adults in Taiwan
Elsevier | 2024
|